OncoPharm cover image

Tale from the Crypt: Belantamab Mafodotin

OncoPharm

00:00

Belantamab mafodotin: history and mechanism

John Bizarro summarizes the drug's BCMA target, mafodotin payload, and its initial accelerated approval in 2020.

Play episode from 00:39
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app